Long-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC)
Clinical trial NCT06155500 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06155500
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-16
- Primary completion
- 2039-01-11
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.